Global Biologics Outsourcing Market Will Reach USD 32,000.0 Million by 2024: Zion Market Research

According to the report, global biologics outsourcing market was valued at around USD 8,420.0 million in the year 2016 and it is expected to reach approximately USD 32,000.0 million by 2024. The global biologics outsourcing market is expected to exhibit a CAGR of more than 18.0% between 2017 and 2024.

Sarasota, Florida, UNITED STATES


New York, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Biologics Outsourcing Market by Product (Antibody, Recombinant Protein, Vaccines, and Others), by Type (Kits & Reagents and Instruments), by Sources (Microbial, Mammalian and Others) and for Applications (Vaccine & Therapeutics Development, Blood & Blood Related Products Testing, Cellular and Gene Therapy, Tissue and Tissue Related Products Testing, and Stem Cell Research): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024”.

According to the report, global biologics outsourcing market was valued at around USD 8,420.0 million in the year 2016 and it is expected to reach approximately USD 32,000.0 million by 2024. The global biologics outsourcing market is expected to exhibit a CAGR of more than 18.0% between 2017 and 2024.

Increasing investments in the research & development of biologics are significantly propelling the outsourcing market among the big as well as small pharmaceutical and biotechnological industries. Also, the robust supply chain ensured by the secondary manufacturer attracts the companies for outsourcing of biologics which will ultimately boost the biologics outsourcing market during the forecast period.

Browse through 28 Tables & 53 Figures spread over 110 Pages and in-depth TOC on "Global Biologics Outsourcing Market: Industry Type, Size, Share, Trends and Forecast 2016 – 2022”.

Request Free Sample copy of Global Biologics Outsourcing Market Report @ https://www.zionmarketresearch.com/sample/biologics-outsourcing-market

Market Report Highlights

  • In Pharma & biotechnology domains, there is a significant role of antibodies thus contributing a dominant share in the biologics outsourcing market.
  • Emerging economies such as China and India are expected to experience a significant market growth owing escalating healthcare infrastructure, advancing technologies and rising initiatives for biologics outsourcing
  • Huge cost and time investment is expected to restrict the growth of biologics outsourcing
  • Antibodies dominates the product segment of the biologics outsourcing market as is widely used for treating number of chronic diseases such as asthma and others
  • The increasing R&D, biologics testing processes, and clinical trials will lift up the use of kits & reagents repeatedly. Thus kits & reagents segment will dominate the market over the forecast period.
  • Microbial sources will dominate the global biologics market by sources.  Due to the presence of a substantial number of products manufactured through the use of microbial sources which will be attributed for largest share during the forecast period.
  • Increasing rate of severe diseases and raising awareness to prevent them will boost the vaccine & therapeutics development application segment throughout the forecast period
  • North America holds the dominant position in the global biologics outsourcing market with around 40% share in 2017
  • China and India are some of the leading countries that contribute the major share in the biologics outsourcing market in the Asia Pacific
  • Slow economic growth less developed healthcare infrastructure and less accessibility of technological advancement in the Middle East & Africa is expected to limit the growth of the market in this region

Browse the full "Biologics Outsourcing Market by Product (Antibody, Recombinant Protein, Vaccines, and Others), by Type (Kits & Reagents and Instruments), by Sources (Microbial, Mammalian and Others) and for Applications (Vaccine & Therapeutics Development, Blood & Blood Related Products Testing, Cellular and Gene Therapy, Tissue and Tissue Related Products Testing, and Stem Cell Research) - Global Industry Analysis, Size, Share, Growth, Trends, and forecast 2017 – 2024" report at https://www.zionmarketresearch.com/report/data-quality-tools-market

The sector’s faster growth above the pharmaceutical industry is helped by the anticipated transition to more outsourcing, as well as the good growth within particular subsectors. Biologics contribute to the major segment by revenue in the pharmaceutical sector and are expected to continue during the forecast period. Biologics have received heavy investment for new facilities, motivated by anticipated growth and margins, whereas small molecules have been less favored. Overall, pharmaceutical outsourced manufacturing is expected to increase in the coming years.

There are several types of products in biologics which are outsourced. High use of antibodies for treating a number of chronic diseases such as asthma, diabetes the segment is expected to dominate biologics outsourcing market throughout the forecast period. The monoclonal antibodies sub-segment in antibodies will contribute to the major share owing to increased applications in the Pharma & biotechnology industries. The ongoing breadth and depth of research and innovation within the antibody engineering field ensures that monoclonal antibodies based products will boost the market.

Ask for Free Analyst Call: https://www.zionmarketresearch.com/ask-to-analyst/biologics-outsourcing-market

 Presence of a substantial number of products manufactured through the use of microbial sources is the major factor that is triggering the growth of the biologics outsourcing market. Thus, the microbial source is contributing a major share in the market growth.

According to the analysts and insights shared by industry experts during primary research, antibody product segment will serve as a prominent opportunity for biologics market and will open up many opportunities for the Biologics outsourcing market. Globalization of the pharmaceutical industry has resulted in outsourcing options becoming more international in nature. Nowadays, contract manufacturing organizations (CMO) exist in a number of different countries and work on behalf of clients in other parts of the world.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/biologics-outsourcing-market

Some of the prominent market players in the Biologics Outsourcing market include Boehringer Ingelheim GmbH, Catalent, Inc., GenScript, Innovent Biologics, Inc., Syngene, Shanghai Medicilon inc., GL Biochem Corporation Ltd., GVK Biosciences Private Limited, Horizon Discovery Group plc. Innovent Biologics, Inc., Selexis SA, Lonza, Abzena PLC, Adimab LLC., among others.

Ask The Analyst for More Information: https://www.zionmarketresearch.com/ask-to-analyst/biologics-outsourcing-market

Global Market Segmentation:

Global Biologics Outsourcing Market: Product Segment Analysis

  • Antibody
    • Monoclonal Antibody
    • Antibody Drug Conjugates
    • Bi-specific Antibody
  • Recombinant Protein
  • Vaccines
  • Others

Global Biologics Outsourcing Market: Type Segment Analysis

  • Kits & Reagents
  • Instruments 

Global Biologics Outsourcing Market: Sources Segment Analysis

  • Microbial
  • Mammalian
  • Others

Global Biologics Outsourcing Market:  Application Segment Analysis

  • Vaccine & Therapeutics Development
  • Blood & Blood-Related Products Testing
  • Cellular and Gene Therapy
  • Tissue and Tissue Related Products Testing
  • Stem Cell Research

Global Biologics Outsourcing Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Rest of North America
  • Europe
    • Germany
    • The UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • The Asia Pacific
    • China
    • Japan
    • India
    • South East Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • The Middle East and Africa
    • GCC Countries
    • South Africa

Rest of Middle East & Africa

Related Reports:

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research

Follow Us Twitter: https://twitter.com/zion_research


        

Contact Data